Document is current
Any future updates will be listed below
-
Authors
Ring, Alexander
Campo, Daniel
Porras, Tania B.
Kaur, Pushpinder
Forte, Victoria A.
Tripathy, Debu
Lu, Janice
Kang, Irene
Press, Michael F.
Jeong, Young Ju
Snow, Anson
Zhu, Yue
Zada, Gabriel
Wagle, Naveed
Lang, Julie E.
- License Information
-
More Information
Article History
First Online: 4 January 2022
Disclosures
: Debasish Tripathy has received research support (paid to the institution) from Novartis, Pfizer, and Polyphor, and consulting fees (paid to self) from AstraZeneca, GlaxoSmithKline, Gilead, Exact Sciences, OncoPep, Novartis, and Pfizer. Irene Kang has received speaker’s bureau fees and consulting fees from Puma Biotechnology, and consulting fees from Bristol Myers Squibb. Michael Press has undertaken a consulting or advisory role for AstraZenecca, Biocartis, Cepheid, Inc., Eli Lilly & Company, Merck & Co., and Puma Biotechnology; has provided expert testimony for Amgen, Inc.; and has private equity interests in TORL Biotherapeutics, LLC.
: The authors declare no competing interests for the presented study. Although ANGLE plc provided research funds to the author’s institution, the authors have no relevant financial disclosures. The study sponsor did not influence data acquisition, analysis, or the decision to publish.
